Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 5A pseudogene 2 (COX5AP2) is annotated as a pseudogene. Pseudogenes are DNA sequences that resemble functional genes but are generally non-coding due to mutations, deletions, or insertions that disrupt their ability to produce a functional protein. They are categorized as unitary, unprocessed (duplicated), or processed pseudogenes, depending on their biogenesis[1][2]. While initially considered “junk,” some pseudogenes have emerging regulatory roles—such as acting as sources for non-coding RNAs or interfering with parental gene regulation[1][2][3]. However, there is no evidence COX5AP2 is a therapeutic target or has direct pharmacological relevance. Studying pseudogenes is technically complex due to high sequence similarity with their parental genes, complicating discrimination in gene expression studies[2]. There are no documented drugs, biomarkers, or specific disease associations for this pseudogene. If you require a protein-coding cytochrome c oxidase subunit (e.g., COX5A), clarify the intended target, as COX5AP2 itself is not a therapeutic target or druggable entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 5A pseudogene 2 (COX5AP2).